These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6891821

  • 1. Experimental tardive dyskinesia.
    Bédard PJ, Boucher R, Larochelle L.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):551-4. PubMed ID: 6891821
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ, Boucher R, Daigle M, Di Paolo T.
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia in Tourette syndrome.
    Golden GS.
    Pediatr Neurol; 1985 Sep; 1(3):192-4. PubMed ID: 3880404
    [Abstract] [Full Text] [Related]

  • 11. Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.
    Naidu PS, Singh A, Kulkarni SK.
    Psychopharmacology (Berl); 2003 Jun; 167(4):418-23. PubMed ID: 12669184
    [Abstract] [Full Text] [Related]

  • 12. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental tardive dyskinesia.
    Gunne LM, Häggström JE.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [Abstract] [Full Text] [Related]

  • 16. Exacerbation of tardive dyskinesia by Joseph disease.
    Browne JL, Hart RR.
    J Clin Psychiatry; 1986 Jun; 47(6):315-6. PubMed ID: 3711030
    [Abstract] [Full Text] [Related]

  • 17. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH.
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [Abstract] [Full Text] [Related]

  • 18. The rubro-olivo-cerebello-rubral loop and postural tremor in the monkey.
    Larochelle L, Bedard P, Boucher R, Poirier LJ.
    J Neurol Sci; 1970 Jul; 11(1):53-64. PubMed ID: 4988983
    [No Abstract] [Full Text] [Related]

  • 19. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM, Dellva MA, Tamura RN, Morgenstern H, Glazer WM, Ferguson K, Tollefson GD.
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [Abstract] [Full Text] [Related]

  • 20. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM, Bárány S.
    Psychopharmacology (Berl); 1979 Jun 21; 63(3):195-8. PubMed ID: 39307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.